Your browser doesn't support javascript.
loading
Nonoperative Management Versus Laparoscopic Appendectomy in Children: A Cost-Effectiveness Analysis.
Adams, Ursula C; Herb, Joshua N; Akinkuotu, Adesola C; Gallaher, Jared R; Charles, Anthony G; Phillips, Michael R.
Affiliation
  • Adams UC; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Herb JN; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Akinkuotu AC; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Gallaher JR; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Charles AG; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Phillips MR; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: MiPhilli@med.unc.edu.
J Surg Res ; 283: 929-936, 2023 03.
Article in En | MEDLINE | ID: mdl-36915021
ABSTRACT

INTRODUCTION:

Nonoperative management (NOM) of acute appendicitis in the pediatric population is highly debated with uncertain cost-effectiveness. We performed a decision tree cost-effectiveness analysis of NOM versus early laparoscopic appendectomy (LA) for acute appendicitis in children.

METHODS:

We created a decision tree model for a simulated cohort of 49,000 patients, the number of uncomplicated appendectomies performed annually, comparing NOM and LA. We included postoperative complications, recurrent appendicitis, and antibiotic-related complications. We used the payer perspective with a 1-year time horizon. Model uncertainty was analyzed using a probabilistic sensitivity analysis. Event probabilities, health-state utilities, and costs were obtained from literature review, Healthcare Cost and Utilization Project, and Medicare fee schedules.

RESULTS:

In the base-case analysis, NOM costs $6530/patient and LA costs $9278/patient on average at 1 y. Quality-adjusted life year (QALY) differences minimally favored NOM compared to LA with 0.997 versus 0.996 QALYs/patient. The incremental cost-effectiveness ratio for NOM over LA was $4,791,149.52/QALY. NOM was dominant in 97.4% of simulations, outperforming in cost and QALYs. A probabilistic sensitivity analysis showed NOM was 99.6% likely to be cost-effective at a willingness-to-pay threshold of $100,000/QALY.

CONCLUSIONS:

Our model demonstrates that NOM is a dominant strategy to LA over a 1-year horizon. We use recent trial data demonstrating higher rates of early and late NOM failures. However, we also incorporate a shorter length of index hospitalizations with NOM, reflecting a contemporary approach to NOM and ultimately driving cost-effectiveness. Long-term follow-up data are needed in this population to assess the cost-effectiveness of NOM over longer time horizons, where healthcare utilization and recurrence rates may be higher.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Appendicitis / Laparoscopy Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Child / Humans Country/Region as subject: America do norte Language: En Journal: J Surg Res Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Appendicitis / Laparoscopy Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Child / Humans Country/Region as subject: America do norte Language: En Journal: J Surg Res Year: 2023 Document type: Article